Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00168792
Status:
TERMINATED
Last Update Posted:
2013-10-29
First Post:
2005-09-09
Brief Title:
A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention PCI as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction ASSENT 4 PCI
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
A Phase IIIb - IV Randomised Open Label Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early PCI as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction ASSENT 4 PCI Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction
Status:
TERMINATED
Status Verified Date:
2013-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To show whether addition of thrombolytic treatment by a single bolus injection of tenecteplase prior to early standard PCI percutaneous coronary intervention will improve the clinical outcome in patients with large acute myocardial infarcts as compared to primary PCI alone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None